A new, non-invasive, wireless hemoglobin measurement device has been shown in two separate trials to be as accurate as invasive devices in testing for anemia and in screening potential blood donors, the product’s manufacturer reports. OrSense, an Israeli maker of non-invasive medical devices for testing blood, this week is introducing Glasswing, its first wireless hemoglobin meter, at the annual Congress of the International Society of Blood Transfusion (ISBT), now underway in Cancun, Mexico. The device, which aids in detecting anemia and hemorrhage as well as in screening blood donors for adequate hemoglobin levels, measures light transmitted through the patient’s finger, eliminating the need for a needle stick.
